Evidence map›Paper›PMID 40827651›Full record

ArticleThe British journal of surgery2025

Comparison of outcomes after living and deceased donor kidney transplantation: UK national cohort study.

James Murray, Annabel Luke, David Wallace, Chris Callaghan, Linda D Sharples

Abstract readComparative Study
In one paragraph

Article in The British journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James MurrayDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-6494-4815
Annabel LukeDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
David WallaceDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-8959-7741
Chris CallaghanDepartment of Nephrology and Transplantation, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Linda D SharplesDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Funding

Amgen Limited
6 · The paper itself

Abstract

backgroundMost kidneys for transplantation come from deceased donors, though healthy live individuals may also donate. Living donor transplants generally show better outcomes than deceased donor transplants, but it is unclear whether this reflects inherent benefits of having a living donor kidney or differences in donor and recipient characteristics. Using data from 10 915 UK kidney-only transplants, the aim of this study was to determine the causal effect of living donors on graft survival, considering all-cause death without graft failure as a competing risk.

methodsThis study used inverse probability of treatment weighting based on propensity scores to adjust for imbalances in baseline variables between recipients of living and deceased donor kidneys implanted between 2010 and 2021. The mean treatment effect, had all patients received kidneys from living donors, was estimated from differences in survival probabilities and restricted mean survival time using weighted competing risks models.

resultsAfter adjustment for key confounders, living donor kidney transplantation (LDKT) was associated with a 6.03% (95% c.i. 4.71% to 7.35%) lower 5-year risk of graft failure compared with deceased donor kidney transplantation (DDKT). Over 7 years, living donor recipients experienced an additional 0.36 (95% c.i. 0.29 to 0.43) years of graft survival. Benefits persisted across clinically relevant LDKT subgroups.

conclusionLDKT is associated with superior graft survival compared with DDKT after adjusting for confounders. Findings highlight the importance of promoting living donor programmes whilst simultaneously identifying opportunities to enhance DDKT. Future work may clarify whether factors such as reduced cold ischaemia time drive these benefits.

Indexed as

Graft SurvivalKidney Failure, ChronicKidney TransplantationLiving DonorsTissue DonorsAdultCohort StudiesFemaleHumansMaleMiddle AgedPropensity ScoreTreatment OutcomeUnited Kingdom

Identifiers

PMID40827651
PMCPMC12362070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.